PRKAA1 and cardiac hypertrophy: Moreover, the protective effects of AMPK on PO-induced cardiac hypertrophy were recently shown to be partially mediated by the inhibition of mTORC1 signaling but not mTORC2 signaling (Li et al., 2014).